ASTM F 2386 : 2004
|
Standard Guide for Preservation of Tissue Engineered Medical Products (TEMPs) (Withdrawn 2013) |
ASTM F 2150 : 2013 : REDLINE
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products |
ASTM F 2312 : 2011 : REDLINE
|
Standard Terminology Relating to Tissue Engineered Medical Products |
ASTM F 2211 : 2002
|
Standard Classification for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2150 : 2019
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Regenerative Medicine and Tissue-Engineered Medical Products |
ASTM F 2312 : 2004
|
Standard Terminology Relating to Tissue Engineered Medical Products |
ASTM F 2212 : 2011
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2739 : 2019
|
Standard Guide for Quantifying Cell Viability and Related Attributes within Biomaterial Scaffolds |
ASTM F 2212 : 2011 : REDLINE
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 1635 : 2016
|
Standard Test Method for in vitro Degradation Testing of Hydrolytically Degradable Polymer Resins and Fabricated Forms for Surgical Implants |
ASTM F 2739 : 2008
|
Standard Guide for Quantitating Cell Viability Within Biomaterial Scaffolds |
ASTM F 2212 : 2002 : R2007 : EDT 1
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2212 : 2019
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2211 : 2013 : R2021
|
Standard Classification for Tissue-Engineered Medical Products (TEMPs) |
ASTM F 2212 : 2002
|
Standard Guide for Characterization of Type I Collagen as a Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2312 : 2011
|
Standard Terminology Relating to Tissue Engineered Medical Products |
ASTM F 1635 : 2016 : REDLINE
|
Standard Test Method for in vitro Degradation Testing of Hydrolytically Degradable Polymer Resins and Fabricated Forms for Surgical Implants |
ASTM F 2210 : 2002 : R2010
|
Standard Guide for Processing Cells, Tissues, and Organs for Use in Tissue Engineered Medical Products (Withdrawn 2015) |
ASTM F 2150 : 2013
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products |
ISO 13022:2012
|
Medical products containing viable human cells — Application of risk management and requirements for processing practices |
ASTM F 2150 : 2002 : EDT 1
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products |
ASTM F 2312 : 2011 : R2020
|
Standard Terminology Relating to Tissue Engineered Medical Products |
ASTM F 2210 : 2002
|
Standard Guide for Processing Cells, Tissues, and Organs for Use in Tissue Engineered Medical Products |
ASTM F 2212 : 2008
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 1635 : 1995
|
Standard Test Method for In Vitro Degradation Testing of Poly (L-lactic Acid) Resin and Fabricated Form for Surgical Implants |
ASTM F 1635 : 2004
|
Standard Test Method for in Vitro Degradation Testing of Hydrolytically Degradable Polymer Resins and Fabricated Forms for Surgical Implants |
ASTM F 2739 : 2016
|
Standard Guide for Quantifying Cell Viability within Biomaterial Scaffolds |
ISO 10993-1:2009
|
Biological evaluation of medical devices Part 1: Evaluation and testing within a risk management process |
ASTM F 2212 : 2002 : R2007
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2212 : 2009
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2211 : 2013
|
Standard Classification for Tissue Engineered Medical Products (TEMPs) |
ASTM D 570 : 2022
|
Standard Test Method for Water Absorption of Plastics |
ISO 18362:2016
|
Manufacture of cell-based health care products Control of microbial risks during processing |
ASTM F 2312 : 2010
|
Standard Terminology Relating to Tissue Engineered Medical Products |
ASTM F 2150 : 2007
|
Standard Guide for Characterization and Testing of Biomaterial Scaffolds Used in Tissue-Engineered Medical Products |
ASTM D 570 : 1998 : R2018
|
Standard Test Method for Water Absorption of Plastics |
ASTM F 1635 : 2011
|
Standard Test Method for in vitro Degradation Testing of Hydrolytically Degradable Polymer Resins and Fabricated Forms for Surgical Implants |
ASTM F 2211 : 2004
|
Standard Classification for Tissue Engineered Medical Products (TEMPs) (Withdrawn 2013) |
ASTM F 2212 : 2008 : EDT 1
|
Standard Guide for Characterization of Type I Collagen as Starting Material for Surgical Implants and Substrates for Tissue Engineered Medical Products (TEMPs) |
ASTM F 2312 : 2003
|
Standard Terminology Relating to Tissue Engineered Medical Products |
ASTM F 1635 : 2004 : REV A
|
Standard Test Method for in Vitro Degradation Testing of Hydrolytically Degradable Polymer Resins and Fabricated Forms for Surgical Implants |